masimo
Latest News

Masimo Announces FDA Clearance of Neonatal Indication for O3® Regional Oximetry

Masimo (NASDAQ: MASI) announced today that O3® Regional Oximetry has received FDA clearance for use on neonatal indication and infant patients […]